These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36385261)

  • 1. Transmission factors and exposure to infections at work and invasive pneumococcal disease.
    Torén K; Albin M; Alderling M; Schiöler L; Åberg M
    Am J Ind Med; 2023 Jan; 66(1):65-74. PubMed ID: 36385261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational exposure to dust and to fumes, work as a welder and invasive pneumococcal disease risk.
    Torén K; Blanc PD; Naidoo RN; Murgia N; Qvarfordt I; Aspevall O; Dahlman-Hoglund A; Schioler L
    Occup Environ Med; 2020 Feb; 77(2):57-63. PubMed ID: 31848233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative occupational exposure to inorganic dust and fumes and invasive pneumococcal disease with pneumonia.
    Torén K; Blanc PD; Naidoo R; Murgia N; Stockfelt L; Schiöler L
    Int Arch Occup Environ Health; 2022 Oct; 95(8):1797-1804. PubMed ID: 35262802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupational risks associated with severe COVID-19 disease and SARS-CoV-2 infection - a Swedish national case-control study conducted from October 2020 to December 2021.
    Torén K; Albin M; Bergström T; Murgia N; Alderling M; Schiöler L; Åberg M
    Scand J Work Environ Health; 2023 Sep; 49(6):386-394. PubMed ID: 37417898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled Corticosteroids Use and Risk of Invasive Pneumococcal Disease in a Population-based Study.
    Torén K; Blanc PD; Qvarfordt I; Aspevall O; Schiöler L
    Ann Am Thorac Soc; 2020 Dec; 17(12):1570-1575. PubMed ID: 32649216
    [No Abstract]   [Full Text] [Related]  

  • 6. Occupational risks for infection with influenza A and B: a national case-control study covering 1 July 2006-31 December 2019.
    Torén K; Albin M; Bergström T; Alderling M; Schioler L; Åberg M
    Occup Environ Med; 2023 Jul; 80(7):377-383. PubMed ID: 37193595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological and conceptual issues regarding occupational psychosocial coronary heart disease epidemiology.
    Burr H; Formazin M; Pohrt A
    Scand J Work Environ Health; 2016 May; 42(3):251-5. PubMed ID: 26960179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012.
    von Mollendorf C; Cohen C; de Gouveia L; Naidoo N; Meiring S; Quan V; Lindani S; Moore DP; Reubenson G; Moshe M; Eley B; Hallbauer UM; Finlayson H; Madhi SA; Conklin L; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
    Pediatr Infect Dis J; 2015 Jan; 34(1):27-34. PubMed ID: 24992122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Influenza Activity and Environmental Conditions With the Risk of Invasive Pneumococcal Disease.
    Berry I; Tuite AR; Salomon A; Drews S; Harris AD; Hatchette T; Johnson C; Kwong J; Lojo J; McGeer A; Mermel L; Ng V; Fisman DN
    JAMA Netw Open; 2020 Jul; 3(7):e2010167. PubMed ID: 32658286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid Analgesic Use and Risk for Invasive Pneumococcal Diseases: A Nested Case-Control Study.
    Wiese AD; Griffin MR; Schaffner W; Stein CM; Greevy RA; Mitchel EF; Grijalva CG
    Ann Intern Med; 2018 Mar; 168(6):396-404. PubMed ID: 29435555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.
    Barry PM; Zetola N; Keruly JC; Moore RD; Gebo KA; Lucas GM
    AIDS; 2006 Feb; 20(3):437-44. PubMed ID: 16439878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.
    Cohen C; von Mollendorf C; de Gouveia L; Naidoo N; Meiring S; Quan V; Nokeri V; Fortuin-de Smit M; Malope-Kgokong B; Moore D; Reubenson G; Moshe M; Madhi SA; Eley B; Hallbauer U; Kularatne R; Conklin L; O'Brien KL; Zell ER; Klugman K; Whitney CG; von Gottberg A;
    Clin Infect Dis; 2014 Sep; 59(6):808-18. PubMed ID: 24917657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating age-stratified influenza-associated invasive pneumococcal disease in England: A time-series model based on population surveillance data.
    Chiavenna C; Presanis AM; Charlett A; de Lusignan S; Ladhani S; Pebody RG; De Angelis D
    PLoS Med; 2019 Jun; 16(6):e1002829. PubMed ID: 31246954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pneumococcal disease following adult allogeneic hematopoietic stem cell transplantation.
    Torda A; Chong Q; Lee A; Chen S; Dodds A; Greenwood M; Larsen S; Gilroy N
    Transpl Infect Dis; 2014 Oct; 16(5):751-9. PubMed ID: 25040633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease in children with cancer: Incidence density, risk factors and isolated serotypes.
    Lages PM; Carlesse F; Boettger BC; Pignatari ACC; Petrilli AS; de Moraes-Pinto MI
    Braz J Infect Dis; 2020; 24(6):489-496. PubMed ID: 33164827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study.
    Chan T; Tay MZ; Kyaw WM; Chow A; Ho HJ
    BMC Infect Dis; 2020 Jun; 20(1):423. PubMed ID: 32552726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older.
    Vila-Corcoles A; Ochoa-Gondar O; Guzmán JA; Rodriguez-Blanco T; Salsench E; Fuentes CM;
    BMC Infect Dis; 2010 Mar; 10():73. PubMed ID: 20298596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
    Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
    Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods.
    Hernández S; Muñoz-Almagro C; Ciruela P; Soldevila N; Izquierdo C; Codina MG; Díaz A; Moraga-Llop F; García-García JJ; Domínguez Á
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014.
    Chowers M; Regev-Yochay G; Mor O; Cohen-Poradosu R; Riesenberg K; Zimhony O; Chemtob D; Stein M; Dagan R; Levy I
    Hum Vaccin Immunother; 2017 Jan; 13(1):216-219. PubMed ID: 27648488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.